Knowledge

Clostridioides difficile

Source 📝

907:(FMT). Healthcare providers can transfer stool from a healthy person to the colon of a patient with recurrent CDI. This process is the most successful treatment for severe CDI with a cure rate around 93%. Fecal matter transplants have also been found to be an effective and safe treatment option for children and young adults. Recurrence rates of CDI in patients treated with a FMT are generally low, around 19%, which makes it very effective at treating chronic CDI cases. However, in some cases, flares of inflammatory bowel disease are a possible side effect of the treatment. The state of the host immune system is important when considering the success of  microbiota-based treatments in clearing infection. Long-term effects of FMT are unknown, as the procedure has only been FDA-approved for recurrent CDI since 2013 and relatively few procedures have been performed. If transplantation is not an option, removal of the infected part of the colon can cure CDI. 782:
colon. Spores can grow and colonize the intestine by antibiotic-induced shifts in the host microbiota. C. difficile secretes mucolytic enzymes like CWp84 to degrade the colonic mucosa. These spores are also capable of adhering to colon cells. Additionally, C. difficile is a motile bacterium that can switch between both the motile and sessile phases, a process regulated by cyclic-di-GMP. On top of that, C. difficile is capable of forming biofilms and cell-to-cell signaling. C. difficile is often transferred from other patients through the hands of healthcare workers or from the overall hospital environment and acquired from ingesting the pathogen. The spores resist the stomach acidity and germinate into their vegetative form in the small intestine. C. difficile can carry a broad spectrum of clinical manifestations, from being asymptomatic to severe colitis and death. As such,
834:
antibodies' neutralization of the cytotoxic effect. C. difficile strains can also be cultured before conducting a cytotoxin assay. These cultures detect the C. difficile strain that can produce toxins. However, these enzyme immunoassays are more widely used due to their rapid turnaround, low cost, and simplicity. Additionally, they show lower sensitivity than toxigenic stool cultures. PCR assays have a shorter turnaround time and a higher sensitivity range than the toxigenic stool culture. Using a PCR-based assay helps avoid detection of asymptomatic patients.
646: 896:, a narrow-spectrum antibiotic. The usual dosage is 200 mg twice a day orally for 10 days. Fidaxomicin is considered to be superior to vancomycin for severe CDI. The major downside of treatment with fidaxomicin is the cost of medication. A 10-day course may cost up to US$ 3500. When a patient is deteriorating or progressing to severe-complicated disease the addition of intravenous tigecycline merits considerations. Patients with high risk of relapse may also benefit from the addition of the monoclonal antibody 53: 91: 73: 664:, shed in faeces. The organism forms heat-resistant aero-tolerant spores that are not killed by alcohol-based hand cleansers or routine surface cleaning, thus, these spores survive in clinical environments for long periods. Any surface, device, or material (e.g., toilets, bathing tubs, and electronic rectal thermometers) that becomes contaminated with faeces may serve as a reservoir for the 926:
prevent the spread of spores within the hospital. Another way to prevent CDIs is wearing personal protective equipment when interacting with C. difficile patients. Furthermore, CDI transmission can be prevented by daily environmental sporicidal disinfection in patient rooms. Also, reducing the length of antibiotic therapy decreases the CDI rates in hospitals.
2026:"Phylogenomic analysis of the family Peptostreptococcaceae (Clostridium cluster XI) and proposal for reclassification of Clostridium litorale (Fendrich et al. 1991) and Eubacterium acidaminophilum (Zindel et al. 1989) as Peptoclostridium litorale gen. nov. comb. nov. and Peptoclostridium acidaminophilum comb. nov" 672:
spores can live for long periods of time on surfaces. Because of this, the bacterium may be cultured from almost any surface. Once spores are ingested, their acid resistance allows them to pass through the stomach unscathed. They germinate and multiply into vegetative cells in the colon upon exposure
925:
infection is spread through the fecal-oral route through ingestion and acid-resistant spores. Appropriate hand hygiene of healthcare workers is vital to remove spores, which includes thoroughly washing one's hands with soap and warm water. Additionally, isolation of patients with acute diarrhea can
833:
A C. difficile infection is often suspected because of foul-smelling diarrhea, but this does not confirm if the patient has a CDI. To confirm a CDI, a cytotoxin assay detects the cell's toxin B (ToxB) cytotoxicity in the fecal eluate. The presence of C. difficile toxin is confirmed by the anti-toxin
824:
of patients with severe disease. New findings show that the loss of the interleukin-10 corresponds to higher levels of interleukin-22, which has been found to be important in a host's response to a C.difficile infection. Thus, IL-10 deficiency can increase a host's defense against the pathogen. This
781:
is transmitted through the oral-fecal route, and many reproduce through spores. The germination of these spores depends on the ability to sense primary bile acids in the liver, like taurocholate, which are sensed by the germinant receptor CspC. Secondary bile acids can inhibit these processes in the
875:
is usually treated with the same antibiotic used to treat the primary infection. Any subsequent infections should not be treated with metronidazole. Occasionally, a standard 10-day course of oral vancomycin will not work. In these cases, a vancomycin taper is the preferred treatment. Patients take
617:
warned of the emergence of an epidemic strain with increased virulence, antibiotic resistance, or both. Resistance to other antibiotics such as metronidazole, the first choice of antimicrobial drug when treating CDI, has been observed in up to 12% of clinical isolates, so as treatment with various
957:
As of 2016, the NAP1 strain has been replaced by novel strains in some areas of British Columbia. These novel strains include NAP2 and NAP4, and some strains that do not have a NAP designation. The frequency of these novel strains increased from 2008 to 2013 in one studied region, displacing the
842:
Patients being treated with antibiotics when symptoms begin should stop taking them, if possible. This break in antibiotic therapy can sometimes lead to spontaneous resolution of symptoms. Patients who do not respond to the cessation of broad-spectrum antibiotics will need to be treated with
3526: 1077:
in 2005 using ultra-high throughput sequencing technology. The tests involved doing 400,000 DNA parallel-sequencing reactions of the bacterium's genome, which had been fragmented for sequencing. These sequences were assembled computationally to form a complete genome sequence.
383:
is commonly known as a hospital and antibiotic associated pathogen, at most one third of infections can be traced to transmission from an infected person in hospitals, and only a small number of antibiotics are directly associated with an elevated risk of developing a
798:
secreted toxins A (TcdA) and B (TcdB), contain immunogenic antigens that are recognised by antibodies and T cells. However, the levels of anti-TcdA and -TcdB IgG antibodies have not been able to discriminate healthy individuals from patients with
3537: 741:
may be able to grow as a result of many of its competitors being killed off. The incubation period is 5–10 days, with a range of 1 day to weeks following antibiotic treatment for antibiotic associated diarrhea. Additionally, carriage of
4352: 859:
is an acceptable option with similar efficacy and even lower recurrence rates than vancomycin. In cases of fulminant CDI, adjuvant therapy with parenteral metronidazole plus oral vancomycin or fidaxomicin is suggested.
3328:"Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)" 815:
infection had significantly more toxin-specific T cells compared to those with mild infection, indicating T cells are playing a key role in fighting this infection. This immune response can further dysregulate
3169:
Cook L, Rees WD, Wong MQ, Peters H, Levings MK, Steiner TS (May 2021). "Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B".
726:
afflicted almost half a million Americans and caused 29,000 deaths in 2011. The study estimated that 40% of cases began in nursing homes or community health-care settings, while 24% occurred in hospitals.
325:, and occur in pairs or short chains. Under the microscope, they appear as long, irregular (often drumstick- or spindle-shaped) cells with a bulge at their terminal ends (forms subterminal spores). Under 3793:"Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies" 1776:
VanInsberghe D, Elsherbini JA, Varian B, Poutahidis T, Erdman S, Polz MF (April 2020). "Diarrhoeal events can trigger long-term Clostridium difficile colonization with recurrent blooms".
407:. The majority of infections are acquired outside of hospitals, and most antibiotics have similar elevated risk of infection on par with many non-antibiotic risk factors, such as using 1046:
in the UK. This was of the strain 630, a virulent and multiple drug-resistant strain isolated in Switzerland in 1982. Scientists at Sanger Institute have sequenced genomes of about 30
540:, a severe form of colonic distention that can put a patient at risk for colon perforation, sepsis and shock. Toxins A and B are glucosyltransferases that target and inactivate the 1703:
McFarland LV, Surawicz CM, Stamm WE (September 1990). "Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients".
437:. Individuals with no history of gastrointestinal disturbances appear unlikely to become asymptomatic carriers. These carriers are thought to be a major reservoir of infection. 1325: 1096:
has a highly diverse epigenome, with 17 high-quality methylation motifs reported so far, the majority pertaining to the 6mA type. Methylation at one of these motifs - CAAAA
811:, which are important in maintaining a healthy gut environment, although in patients with severe infection these cells are impaired. Interestingly, individuals with severe 1930:
Lawson PA, Citron DM, Tyrrell KL, Finegold SM (August 2016). "Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938".
746:
with high levels of toxins is common in young children, while disease is rare. The production of one or even both toxins is not always sufficient for producing symptoms.
733:
is common in the human digestive system. However, it is a poor competitor, and is often outcompeted for nutrients by other bacteria in the digestive system. As a result,
4393: 3377:"Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections" 719:
infects pigs, calves, and humans, and inhabits a natural reservoir of soil, faeces of domestic animals and humans, sewage, the human intestinal tract, and retail meat.
429:
was present in 2–5% of the adult population, more recent research indicates colonization is closely associated with a history of unrelated diarrheal illnesses, such as
677:
advocates the use of soap in addition to alcohol solutions to limit the spread of the spores. Sporulation was shown to be significantly reduced after inactivation of
3616:"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults" 5417: 5283: 532:), although their relative contributions have been debated. The diarrhea may range from a few days of intestinal fluid loss to life-threatening pseudomembranous 2746: 1246: 4056:"Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region" 17: 2617: 803:
infection, meaning they have limited clinical use. Recent work has shown these toxins are also recognised by helper CD4+ T cells, predominantly by the
593:
and physiological factors of the bacterium (spore formation, protective effects of the pseudomembrane). The emergence of a new, highly toxic strain of
536:, which is associated with intense inflammation of the colon and formation of pseudomembranes on the intestinal mucosal surface. This may progress to 3666:
Di Bella S, Nisii C, Petrosillo N (July 2015). "Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature".
1144: 965:; both strains became more common after trehalose was introduced as a food additive in the early 2000s, thus increasing dietary trehalose intake. 5391: 4386: 5296: 2518:"Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options" 979: 3936: 2647:"Epigenomic characterization of Clostridioides difficile finds a conserved DNA methyltransferase that mediates sporulation and pathogenesis" 863:
Approximately 15-30% of patients who successfully complete therapy of primary infection with metronidazole or vancomycin will experience a
4814: 4227: 2792: 2584: 4379: 3703:"Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies" 1479: 883:
tends to be more severe than previous infections. Long-term treatment with a vancomycin taper supplemented with probiotics, especially
376: 1215: 2293:"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality" 1321: 5378: 5270: 3283:
Rupnik M, Wilcox MH, Gerding DN (July 2009). "Clostridium difficile infection: new developments in epidemiology and pathogenesis".
1250: 704:
fluctuates considerably – fluctuating from being below the limit of detection to high levels of shedding from one day to the next.
3426:"2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea" 3225:"Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection" 950:
027; the differing terminology reflects the predominant techniques used for epidemiological typing. This strain is referred to as
5404: 4670: 2266: 5468: 2554: 681:'s DNA methyltransferase CamA, raising the prospect of developing a drug that may inhibit this bacterium in a specific manner. 1455: 5409: 2493: 4804: 3072:"Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B" 1085:
genomes from 486 cases arising over four years in Oxfordshire using next-generation sequencing technologies from Illumina.
4694: 1738:
McFarland LV, Mulligan ME, Kwok RY, Stamm WE (January 1989). "Nosocomial acquisition of Clostridium difficile infection".
5483: 2438:"Activity of Hospital Disinfectants against Vegetative Cells and Spores of Clostridioides difficile Embedded in Biofilms" 820:
expression. This is further evidenced by the recovery of the toxin-specific Th17 cells and microRNA expression following
3842:"Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection" 847:
spores. Primary infections are typically treated with vancomycin, with a usual dosage of 125 mg every 6 hours. The
2515:
Di Bella S, Sanson G, Monticelli J, Zerbato V, Principe L, Giuffrè M, et al. (February 29, 2024). Staley C (ed.).
385: 33: 1819:
Eyre DW, Griffiths D, Vaughan A, Golubchik T, Acharya M, O'Connor L, et al. (November 12, 2013). Chang YF (ed.).
5040: 4421: 4371: 2736: 855:
due to its greater efficacy, safety profile, and lower recurrence rates. In patients who cannot tolerate vancomycin,
1167:
Hall IC, O'toole E (1935). "Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe,
943: 511: 500: 358: 354: 574:, which inhibits the growth of other microbes in its vicinity and allows it to outcompete normal human gut flora. 5478: 5356: 5301: 4645: 4625: 4593: 4574: 914:
recurrence has been of great interest, but there has been no consensus on significantly associated risk factors.
5473: 708:
in carriers appear to trigger periods of increased shedding which may be an important factor for transmission.
563:
Additional virulence factors include an adhesion factor that mediates the binding to human colonic cells and a
2175:"Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins" 4548: 2606: 526: 379:, in 2017 there were 223,900 cases in hospitalized patients and 12,800 deaths in the United States. Although 876:
decreasing doses of vancomycin over a period of up to 3 months, depending on the severity of the infection.
5183: 4857: 4466: 3615: 90: 4009:
Tschudin-Sutter S, Kuijper EJ, Durovic A, Vehreschild MJ, Barbut F, Eckert C, et al. (October 2018).
3908:"Predicting Recurrence of C. difficile Colitis Using Bacterial Virulence Factors: Binary Toxin Is the Key" 4686: 4565: 904: 821: 786:
is the most prevalent U.S. healthcare infection, posing serious health risks and substantial care costs.
610: 609:, said to be causing geographically dispersed outbreaks in North America, was reported in 2005. The U.S. 322: 3565:
Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. (April 2013).
4843: 2075:"Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects" 1347:
Moreno MA, Furtner F, Rivara FP (June 2013). "Clostridium difficile: a cause of diarrhea in children".
321:
bacteria, ubiquitous in nature and especially prevalent in soil. Its vegetative cells are rod-shaped,
5432: 4598: 737:
is kept to a manageable number. If the sudden introduction of an antibiotic disrupts the microbiome,
674: 553: 4105:
Collins J, Robinson C, Danhof H, Knetsch CW, van Leeuwen HC, Lawley TD, et al. (January 2018).
5078: 4779: 4639: 4485: 1605:"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection" 1113: 705: 219: 4011:"Guidance document for prevention of Clostridium difficile infection in acute healthcare settings" 3527:"Treatment of Recurrent Clostridium difficile Colitis with Vancomycin and Saccharomyces boulardii" 2126:"The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile" 5029: 4740: 4535: 4358: 3907: 3614:
van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, et al. (December 2021).
2921:"Management of Clostridioides difficile infection: Diagnosis, Treatment, and Future Perspectives" 1274:"Human Colon Cancer-Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in Mice" 885: 461:. This new name reflects the taxonomic differences between this species and members of the genus 3701:
Giacobbe DR, Dettori S, Di Bella S, Vena A, Granata G, Luzzati R, et al. (September 2020).
3326:
McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. (March 2018).
5396: 5212: 5135: 4928: 4587: 4542: 4491: 2645:
Oliveira PH, Ribis JW, Garrett EM, Trzilova D, Kim A, Sekulovic O, et al. (January 2020).
1501:
Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O'Connor L, et al. (September 2013).
1447: 4220: 2960:
Monaghan TM, Negm OH, MacKenzie B, Hamed MR, Shone CC, Humphreys DP, et al. (July 2017).
5445: 5314: 5156: 5149: 4988: 4798: 4734: 4509: 3840:
Littmann ER, Lee JJ, Denny JE, Alam Z, Maslanka JR, Zarin I, et al. (February 2, 2021).
2788: 2576: 590: 541: 175: 142: 3375:
Mullane KM, Miller MA, Weiss K, Lentnek A, Golan Y, Sears PS, et al. (September 2011).
3114:
Bocchetti M, Ferraro MG, Melisi F, Grisolia P, Scrima M, Cossu AM, et al. (June 2023).
2966:
toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic
2436:
Rashid T, Haghighi F, Hasan I, Bassères E, Alam MJ, Sharma SV, et al. (December 2019).
2291:
Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. (December 2005).
1471: 1439: 5365: 5257: 5162: 5141: 4809: 4748: 4528: 4521: 4175: 4118: 3853: 2242: 1880:"List of new names and new combinations previously effectively, but not validly, published" 1832: 1272:
Drewes JL, Chen J, Markham NO, Knippel RJ, Domingue JC, Tam AJ, et al. (August 2022).
1199: 350: 3424:
Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. (November 2017).
3021:"IgG antibody response to toxins A and B in patients with Clostridium difficile infection" 8: 4704: 4664: 4514: 4417: 4246:"Microevolutionary analysis of Clostridium difficile genomes to investigate transmission" 4162:
He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, et al. (April 2010).
4051: 3567:"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections" 1184: 361:
and Clostridioides difficile transferase. Under stress conditions, the bacteria produce
5288: 4244:
Didelot X, Eyre DW, Cule M, Ip CL, Ansari MA, Griffiths D, et al. (December 2012).
4179: 4122: 3857: 3146: 3115: 2246: 1836: 1680: 1653: 1242: 1104:
disease transmission, as well as cell length, biofilm formation, and host colonization.
618:
antibiotics continues, more diverse and stronger resistances will continue to evolve in
5488: 5002: 4885: 4326: 4299: 4272: 4245: 4198: 4163: 4139: 4106: 4082: 4055: 3986: 3959: 3882: 3841: 3822: 3768: 3751: 3727: 3702: 3648: 3596: 3503: 3474: 3450: 3425: 3401: 3376: 3352: 3327: 3308: 3257: 3224: 3205: 3047: 3020: 2996: 2961: 2896: 2869: 2842: 2815: 2741: 2671: 2646: 2462: 2437: 2413: 2382: 2322: 2258: 2101: 2074: 2050: 2025: 2001: 1966: 1904: 1879: 1855: 1820: 1801: 1629: 1604: 1580: 1551: 1550:
Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, et al. (October 1, 2017).
1527: 1502: 1408: 1383: 1298: 1273: 1059: 939: 689: 684:
Susceptibility to colonization appears to be triggered by diarrheal illnesses, such as
365:
that are able to tolerate extreme conditions that the active bacteria cannot tolerate.
314: 244: 197: 85: 4401: 3679: 2199: 2174: 2150: 2125: 1652:
Rafey A, Jahan S, Farooq U, Akhtar F, Irshad M, Nizamuddin S, et al. (May 2023).
692:
or laxative abuse; people without a history of diarrheal illnesses who are exposed to
5440: 5422: 5309: 5174: 4905: 4729: 4699: 4331: 4277: 4203: 4144: 4087: 4032: 3991: 3928: 3887: 3869: 3814: 3773: 3732: 3683: 3652: 3640: 3588: 3508: 3455: 3406: 3357: 3300: 3262: 3244: 3209: 3197: 3151: 3093: 3052: 3001: 2942: 2901: 2847: 2717: 2676: 2546: 2538: 2467: 2418: 2363: 2314: 2229: 2204: 2155: 2106: 2055: 2006: 1947: 1909: 1860: 1805: 1793: 1755: 1720: 1685: 1634: 1585: 1532: 1451: 1440: 1413: 1364: 1360: 1303: 1200:"Études de systématique bactérienne. IV. Critique de la conception actuelle du genre 1066: 1055: 3600: 3312: 2517: 2326: 2262: 961:
Two strains, ribotypes RT078 and RT027, can live on low concentrations of the sugar
903:
Patients who do not respond to traditional antibiotic therapy may be eligible for a
5126: 4321: 4311: 4267: 4257: 4193: 4183: 4134: 4126: 4077: 4067: 4022: 3981: 3971: 3920: 3877: 3861: 3826: 3804: 3763: 3750:
AKAGAWA S, AKAGAWA Y, YAMANOUCHI S, KIMATA T, TSUJI S, KANEKO K (August 25, 2020).
3722: 3714: 3675: 3630: 3578: 3498: 3490: 3445: 3437: 3396: 3388: 3347: 3339: 3292: 3252: 3236: 3187: 3179: 3141: 3131: 3083: 3042: 3032: 2991: 2981: 2932: 2891: 2881: 2837: 2827: 2707: 2666: 2658: 2530: 2457: 2449: 2408: 2398: 2353: 2304: 2250: 2194: 2190: 2186: 2145: 2137: 2096: 2086: 2045: 2037: 1996: 1986: 1943: 1939: 1899: 1891: 1850: 1840: 1785: 1747: 1712: 1675: 1665: 1624: 1616: 1575: 1567: 1522: 1514: 1403: 1395: 1356: 1293: 1285: 1180: 1043: 804: 661: 645: 549: 400: 273: 2962:"High prevalence of subclass-specific binding and neutralizing antibodies against 1384:"Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics" 700:, they remain carriers for year-long time scales, but the day-to-day abundance of 5235: 4899: 4613: 4440: 4231: 3183: 3088: 3071: 2937: 2920: 2485: 1845: 1503:"Diverse sources of C. difficile infection identified on whole-genome sequencing" 1289: 598: 537: 422: 362: 306: 52: 4164:"Evolutionary dynamics of Clostridium difficile over short and long time scales" 1751: 986: 5057: 4262: 4168:
Proceedings of the National Academy of Sciences of the United States of America
3865: 3718: 2696:"Clostridium difficile in food and domestic animals: a new foodborne pathogen?" 2254: 1716: 1399: 1027: 767: 763: 685: 453: 434: 430: 152: 4027: 4010: 3924: 3809: 3792: 3635: 2662: 1789: 5462: 5341: 4603: 4456: 4316: 3873: 3248: 3136: 2542: 1991: 1116: 852: 630: 602: 564: 404: 299: 132: 4188: 2387:
Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms"
5035: 4720: 4335: 4281: 4207: 4148: 4091: 4072: 4036: 3995: 3976: 3932: 3891: 3818: 3777: 3736: 3687: 3644: 3592: 3512: 3459: 3410: 3361: 3304: 3266: 3201: 3155: 3097: 3056: 3005: 2946: 2905: 2851: 2721: 2680: 2550: 2471: 2422: 2403: 2367: 2318: 2208: 2110: 2059: 2041: 2010: 1951: 1913: 1895: 1864: 1797: 1689: 1638: 1589: 1536: 1417: 1368: 1307: 897: 606: 522: 255: 72: 4353:
Pathogen Safety Data Sheets: Infectious Substances – Clostridium Difficile
3343: 2569: 2159: 2091: 1759: 1724: 1571: 1518: 696:
spores will not necessarily become carriers. Once people are colonized by
5350: 5189: 4964: 4934: 3791:
Chen T, Zhou Q, Zhang D, Jiang F, Wu J, Zhou JY, et al. (May 2018).
3441: 3392: 3240: 3037: 2886: 2832: 2534: 2453: 2309: 2292: 1821:"Asymptomatic Clostridium difficile colonisation and onward transmission" 1670: 1620: 1322:"Johns Hopkins Doctors Discover That a Common Infection May Cause Cancer" 1004: 893: 856: 568: 496: 463: 447: 396: 4130: 4107:"Dietary trehalose enhances virulence of epidemic Clostridium difficile" 4008: 3296: 3192: 3070:
Cook L, Rees WD, Wong MQ, Kwok WW, Levings MK, Steiner TS (March 2021).
2986: 5383: 5275: 5117: 5102: 5091: 4954: 4835: 4763: 4608: 4582: 4408: 3583: 3566: 2814:
Smits WK, Lyras D, Lacy DB, Wilcox MH, and Kuijper EJ (April 7, 2017).
2073:
Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A (May 2016).
1051: 1017: 947: 848: 653:
amongst other microflora from infected patient fecal sample suspension.
582: 392: 334: 326: 122: 64: 5249: 4060:
The Canadian Journal of Infectious Diseases & Medical Microbiology
2141: 1775: 5062: 4969: 4826: 4789: 4634: 4412: 4404: 4054:, Marra F, Kibsey P, Tan K, Umlandt P, et al. (March 29, 2016). 3494: 2342:"Clostridium difficile: responding to a new threat from an old enemy" 2123: 1124: 962: 507: 251: 112: 5206: 825:
could be of particular interest in future research for treatments.
552:
of the low molecular mass GTP-binding Rho proteins. There is also a
5335: 5229: 4994: 4918: 4875: 4768: 4475: 4445: 3564: 2712: 2695: 2358: 2341: 1971:
Biology: Sporulation, Germination, and Corresponding Therapies for
1132: 817: 759: 622:
populations, further complicating attempts at effective treatment.
557: 518: 408: 372: 346: 318: 254:
known for causing serious diarrheal infections, and may also cause
102: 2124:
Just I, Selzer J, von Eichel-Streiber C, Aktories K (March 1995).
548:
depolymerization by a mechanism correlated with a decrease in the
5262: 5244: 5008: 4891: 4431: 3116:"Overview of current detection methods and microRNA potential in 2230:"The chemical weapon that helps bacterium wreak havoc in the gut" 2072: 2030:
International Journal of Systematic and Evolutionary Microbiology
1884:
International Journal of Systematic and Evolutionary Microbiology
864: 614: 533: 425:
without causing disease. Although early estimates indicated that
302: 2870:"Current Status of Clostridium difficile Infection Epidemiology" 1243:"LPSN - List of Prokaryotic names with Standing in Nomenclature" 5370: 3613: 2514: 1070: 994: 634: 338: 3749: 3113: 867:. About 40% of these patients will continue to have recurrent 625:
Disinfecting surfaces in hospitals may also be challenging as
279: 3752:"Development of the gut microbiota and dysbiosis in children" 1818: 1654:"Antibiotics Associated With Clostridium difficile Infection" 934:
In 2005, molecular analysis led to the identification of the
545: 492: 412: 4104: 4049: 3325: 2918: 2644: 2173:
Barth H, Aktories K, Popoff MR, Stiles BG (September 2004).
3700: 3223:
Cribas ES, Denny JE, Maslanka JR, Abt MC (April 16, 2021).
2599: 2435: 2024:
Galperin MY, Brover V, Tolstoy I, Yutin N (December 2016).
1929: 2959: 2607:"WHO Guidelines on Hand Hygiene in Health Care: a Summary" 2577:"Clostridium difficile Infection Information for Patients" 2023: 1737: 1602: 471:. As of 2018, the only other species in this new genus is 32:
This article is about the bacterium. For the disease, see
3374: 3019:
Wullt M, Norén T, Ljungh A, Åkerlund T (September 2012).
2919:
Cymbal M, Chatterjee A, Baggott B, Auron M (March 2024).
2172: 287: 3018: 1271: 892:
After three relapses, patients may be treated with oral
4214: 4161: 3665: 2290: 1603:
Brown KA, Khanafer N, Daneman N, Fisman DN (May 2013).
1500: 958:
originally more common and recognizable NAP1 bacteria.
3960:"Clostridium difficile Infection: A Worldwide Disease" 3222: 1702: 1651: 1247:
Deutsche Sammlung von Mikroorganismen und Zellkulturen
1081:
In 2012, scientists at University of Oxford sequenced
660:
is transmitted from person or animal to person by the
942:
analysis, as North American pulse-field-type NAP1 by
353:-negative, and produces up to three types of toxins: 290: 276: 3839: 2813: 2478: 560:), but its role in disease is not fully understood. 284: 191:(Hall & O'Toole, 1935) Lawson & Rainey, 2016 4355:, Public Health Agency, Canada, September 10, 2014. 4098: 3479:
Infection: Risk Factors, Treatment, and Prevention"
3282: 2583:. U.S. Centers for Disease Control and Prevention. 2486:"Bleach does not kill common superbug, study finds" 1346: 1131: strains carry a diverse and prevalent set of 1127:. Both environmentally and clinically derived  1123:, ranging in genome size from about 30 to about 60 333:cells are Gram-positive and show optimum growth on 3906: 3904: 3790: 3423: 3168: 2868:Lessa FC, Gould CV, McDonald LC (August 1, 2012). 2867: 2516: 2228: 770:that can be severe, loss of appetite, and nausea. 4243: 1549: 1314: 5460: 4300:"Clostridium difficile phages: still difficult?" 4297: 3069: 1979:Frontiers in Cellular and Infection Microbiology 1472:"Clostridioides difficile Infection | HAI | CDC" 1381: 1160: 4293: 4291: 3560: 3558: 3278: 3276: 3109: 3107: 2863: 2861: 2640: 2638: 1925: 1923: 1771: 1769: 1464: 1166: 1100:was shown to impact sporulation, a key step in 889:, is associated with a higher rate of success. 3905:Stewart DB, Berg A, Hegarty J (January 2013). 2772:(Fifth ed.). Elsevier Mosby. p. 412. 1138: 4387: 3668:International Journal of Antimicrobial Agents 337:at human body temperatures in the absence of 4288: 4237: 4155: 4043: 4002: 3951: 3898: 3833: 3784: 3743: 3694: 3659: 3607: 3555: 3466: 3417: 3368: 3319: 3273: 3216: 3162: 3104: 3063: 3012: 2953: 2912: 2858: 2807: 2728: 2693: 2687: 2635: 2508: 2429: 2374: 2333: 2166: 2066: 2017: 1958: 1920: 1871: 1812: 1766: 1645: 1596: 1543: 1494: 851:regimen has replaced the traditional use of 3957: 2789:"Could you have deadly diarrhea (C. Diff)?" 2783: 2781: 2779: 2761: 2346:Infection Control and Hospital Epidemiology 2286: 2284: 2221: 2117: 1877: 1731: 1696: 1433: 1431: 1429: 1427: 1375: 1340: 1265: 1191: 577: 567:. The bacterium also produces the chemical 445:The species was transferred from the genus 4394: 4380: 2974:Clinical and Experimental Gastroenterology 2179:Microbiology and Molecular Biology Reviews 1964: 1556:Infection in Adults: A Case-Control Study" 1382:Kordus SL, Thomas AK, Lacy DB (May 2022). 71: 51: 4325: 4315: 4271: 4261: 4197: 4187: 4138: 4081: 4071: 4026: 3985: 3975: 3881: 3808: 3767: 3726: 3634: 3582: 3502: 3449: 3400: 3351: 3256: 3191: 3145: 3135: 3087: 3046: 3036: 2995: 2985: 2936: 2895: 2885: 2841: 2831: 2711: 2670: 2461: 2412: 2402: 2357: 2308: 2198: 2149: 2100: 2090: 2049: 2000: 1990: 1903: 1854: 1844: 1679: 1669: 1628: 1579: 1526: 1407: 1297: 938:strain type characterized as group BI by 589:infections may be difficult, due both to 421:can also become established in the human 3958:Burke KE, Lamont JT (January 29, 2014). 3571:The American Journal of Gastroenterology 3534:The American Journal of Gastroenterology 3519: 2776: 2737:"Death Toll From C. Difficile Is Raised" 2339: 2281: 1424: 1173:American Journal of Diseases of Children 1073:of the highly virulent Quebec strain of 1038:The first complete genome sequence of a 644: 4671:Cutaneous Streptococcus iniae infection 4368:- the Bacterial Diversity Metadatabase. 4234:– Institute of Public Affairs, Montreal 3472: 2749:from the original on September 29, 2017 2734: 2581:Health-care Associated Infections (HAI) 2380: 2215: 1552:"Risk Factors for Community-Associated 1437: 1148:infection § Etymology and pronunciation 789: 467:, while maintaining the common name as 14: 5461: 2767: 2694:Gould LH, Limbago B (September 2010). 2496:from the original on November 22, 2023 1446:(4th ed.). McGraw Hill. pp.  1197: 5211: 5210: 4375: 2442:Antimicrobial Agents and Chemotherapy 2130:The Journal of Clinical Investigation 1878:Oren A, Garrity GM (September 2017). 1609:Antimicrobial Agents and Chemotherapy 1253:from the original on November 8, 2022 749: 457:in 2016, thus giving it the binomial 80:Electron micrograph of the bacterium 5433:b212b1f2-123c-4ff3-8b3d-60313e54feab 4805:Staphylococcal scalded skin syndrome 1185:10.1001/archpedi.1935.01970020105010 4015:Clinical Microbiology and Infection 3939:from the original on March 21, 2024 3913:Journal of Gastrointestinal Surgery 3623:Clinical Microbiology and Infection 2795:from the original on March 30, 2017 2587:from the original on March 30, 2017 2529:(2). Mayuresh Abhyankar: e0013523. 2297:The New England Journal of Medicine 1740:The New England Journal of Medicine 1507:The New England Journal of Medicine 1230: 633:, including high concentrations of 24: 18:Clostridioides difficile (bacteria) 2557:from the original on March 4, 2024 2269:from the original on July 28, 2020 1705:The Journal of Infectious Diseases 1482:from the original on March 8, 2020 1218:from the original on July 28, 2020 773: 34:Clostridioides difficile infection 25: 5500: 5041:Clostridial necrotizing enteritis 4346: 4298:Hargreaves KR, Clokie MR (2014). 3680:10.1016/j.ijantimicag.2015.03.012 3124:World Journal of Gastroenterology 2816:"Clostridium difficile infection" 2241:(7723): 288. September 14, 2018. 2185:(3): 373–402, table of contents. 1328:from the original on May 26, 2023 1238:Species: Clostridioides difficile 673:to bile acids. Consequently, the 482: 3797:Journal of Crohn's & Colitis 3473:Song JH, Kim YS (January 2019). 2623:from the original on May 9, 2020 2381:Banawas SS (February 21, 2018). 1361:10.1001/jamapediatrics.2013.2551 1107: 1042:strain was published in 2005 by 944:pulsed-field gel electrophoresis 871:infection. The first relapse of 722:A 2015 CDC study estimated that 272: 89: 4646:Group B streptococcal infection 4594:Group A streptococcal infection 3707:Infectious Diseases and Therapy 3025:Clinical and Vaccine Immunology 2735:Belluck P (February 25, 2015). 1050:isolates using next-generation 843:antibiotics capable of killing 640: 371:is an important emerging human 2820:Nature Reviews Disease Primers 2191:10.1128/MMBR.68.3.373-402.2004 1965:Zhu D, Sorg JA, Sun X (2018). 1944:10.1016/j.anaerobe.2016.06.008 1560:Open Forum Infectious Diseases 1438:Ryan KJ, Ray CG, eds. (2004). 544:. Toxin B (cytotoxin) induces 13: 1: 5469:Antibiotic-resistant bacteria 2523:Clinical Microbiology Reviews 2391:BioMed Research International 1208:Annales de l'Institut Pasteur 1153: 917: 711: 517:), both of which may produce 495:. The best-characterized are 5184:Erysipelothrix rhusiopathiae 3756:National Library of Medicine 3430:Clinical Infectious Diseases 3381:Clinical Infectious Diseases 3332:Clinical Infectious Diseases 3285:Nature Reviews. Microbiology 3184:10.1053/J.GASTRO.2021.01.009 3089:10.1053/J.GASTRO.2020.11.043 2938:10.1016/j.amjmed.2024.03.024 2874:Clinical Infectious Diseases 2700:Clinical Infectious Diseases 1846:10.1371/journal.pone.0078445 1442:Sherris Medical Microbiology 1388:Nature Reviews. Microbiology 1290:10.1158/2159-8290.CD-21-1273 1088: 837: 828: 7: 2340:McDonald LC (August 2005). 1752:10.1056/NEJM198901263200402 1139:Etymology and pronunciation 905:fecal microbiota transplant 822:Fecal microbiota transplant 611:Centers for Disease Control 440: 218:(Hall & O'Toole, 1935) 10: 5505: 5484:Bacteria described in 1935 4263:10.1186/gb-2012-13-12-r118 3866:10.1038/s41467-020-20793-x 3719:10.1007/s40121-020-00314-5 2255:10.1038/d41586-018-06650-4 1400:10.1038/s41579-021-00660-2 1142: 1069:in Montreal sequenced the 929: 879:Each subsequent relapse of 227:Peptoclostridium difficile 31: 5325: 5219: 5173: 5125: 5116: 5089: 5055: 5019: 4978: 4962: 4953: 4916: 4873: 4825: 4788: 4777: 4762: 4718: 4685: 4656: 4624: 4599:Streptococcal pharyngitis 4573: 4564: 4502: 4474: 4465: 4454: 4439: 4430: 4304:Frontiers in Microbiology 4028:10.1016/j.cmi.2018.02.020 3925:10.1007/s11605-012-2056-6 3636:10.1016/j.cmi.2021.09.038 2663:10.1038/s41564-019-0613-4 2614:World Health Organization 1790:10.1038/s41564-020-0668-2 1026: 1015: 1003: 993: 978: 968: 900:to the standard of care. 675:World Health Organization 491:strains produce multiple 473:Clostridioides mangenotii 210:Hall & O'Toole, 1935 203: 196: 181: 174: 86:Scientific classification 84: 79: 70: 59: 50: 43: 5289:clostridioides-difficile 5221:Clostridioides difficile 5079:Pseudomembranous colitis 5073:Clostridioides difficile 4317:10.3389/fmicb.2014.00184 3137:10.3748/wjg.v29.i22.3385 3118:Clostridioides difficile 1992:10.3389/fcimb.2018.00029 1969:Clostridioides difficile 1717:10.1093/infdis/162.3.678 1146:Clostridioides difficile 1119:have been isolated from 1094:Clostridioides difficile 940:restriction endonuclease 731:Clostridioides difficile 717:Clostridioides difficile 658:Clostridioides difficile 578:Antimicrobial resistance 459:Clostridioides difficile 419:Clostridioides difficile 369:Clostridioides difficile 240:Clostridioides difficile 185:Clostridioides difficile 45:Clostridioides difficile 5030:Clostridium perfringens 4741:Urinary tract infection 4189:10.1073/pnas.0914322107 3810:10.1093/ecco-jcc/jjy031 3577:(4): 478–98, quiz 499. 886:Saccharomyces boulardii 5479:Gram-positive bacteria 5136:Ureaplasma urealyticum 4929:Listeria monocytogenes 4633:bacitracin resistant, 4492:Pneumococcal infection 3977:10.5009/gnl.2014.8.1.1 3229:Infection and Immunity 2042:10.1099/ijsem.0.001548 1896:10.1099/ijsem.0.002278 1112:At least eight mainly 762:(at least three loose 654: 525:in infected patients ( 477:Clostridium mangenotii 258:. It is known also as 5474:Peptostreptococcaceae 5423:clostridium-difficile 5357:Clostridium difficile 5327:Clostridium difficile 5157:Mycoplasma pneumoniae 5150:Mycoplasma genitalium 4989:Clostridium botulinum 4735:Enterococcus faecalis 4510:Viridans streptococci 4361:Clostridium difficile 4230:May 22, 2022, at the 3846:Nature Communications 3477:Clostridium difficile 2964:Clostridium difficile 2492:. November 22, 2023. 2385:Clostridium difficile 2092:10.3390/toxins8050134 1554:Clostridium difficile 1519:10.1056/NEJMoa1216064 766:a day), dehydration, 648: 601:antibiotics, such as 591:antibiotic resistance 542:Rho family of GTPases 248:Clostridium difficile 215:Clostridium difficile 143:Peptostreptococcaceae 5163:Mycoplasma pneumonia 5142:Ureaplasma infection 4852:novobiocin resistant 4810:Toxic shock syndrome 4749:Enterococcus faecium 4073:10.1155/2016/8207418 3241:10.1128/IAI.00730-20 3120:infection screening" 3038:10.1128/CVI.00210-12 2880:(Suppl 2): S65–S70. 2833:10.1038/nrdp.2016.20 2770:Medical Microbiology 2616:. 2009. p. 31. 2535:10.1128/cmr.00135-23 2454:10.1128/AAC.01031-19 2404:10.1155/2018/8414257 2310:10.1056/NEJMoa051639 1671:10.7759/cureus.39029 1621:10.1128/AAC.02176-12 790:Host immune response 351:superoxide dismutase 63:colonies on a blood 5095:(non-spore forming) 4705:Streptococcus bovis 4665:Streptococcus iniae 4413:Infectious diseases 4180:2010PNAS..107.7527H 4131:10.1038/nature25178 4123:2018Natur.553..291C 3858:2021NatCo..12..755L 3629:(Suppl 2): S1–S21. 3344:10.1093/cid/cix1085 3297:10.1038/nrmicro2164 3178:(6): 2155–2158.e4. 3082:(4): 1410–1413.e4. 2987:10.2147/CEG.S133939 2791:. January 4, 2019. 2651:Nature Microbiology 2247:2018Natur.561S.288. 1837:2013PLoSO...878445E 1778:Nature Microbiology 1572:10.1093/ofid/ofx171 1478:. January 2, 2020. 1324:. August 24, 2022. 1169:Bacillus difficilis 975: 974:Genomic information 629:spores resist many 475:(formerly known as 375:; according to the 309:-forming bacteria. 207:Bacillus difficilis 27:Species of bacteria 5003:Clostridium tetani 4886:Bacillus anthracis 4503:optochin resistant 4418:Bacterial diseases 3584:10.1038/ajg.2013.4 3442:10.1093/cid/cix669 3393:10.1093/cid/cir404 2887:10.1093/cid/cis319 2742:The New York Times 1198:Prévot AR (1938). 1054:technologies from 1028:Year of completion 973: 910:The prediction of 758:infection include 750:Signs and symptoms 655: 5456: 5455: 5441:Open Tree of Life 5310:Open Tree of Life 5213:Taxon identifiers 5204: 5203: 5200: 5199: 5175:Anaeroplasmatales 5112: 5111: 5051: 5050: 4949: 4948: 4945: 4944: 4869: 4868: 4758: 4757: 4714: 4713: 4681: 4680: 4560: 4559: 4174:(16): 7527–7532. 4117:(7688): 291–294. 4021:(10): 1051–1054. 3543:on August 9, 2017 3130:(22): 3385–3399. 2768:Murray P (2005). 2303:(23): 2442–2449. 2142:10.1172/JCI117747 2036:(12): 5506–5513. 1513:(13): 1195–1205. 1457:978-0-8385-8529-0 1067:McGill University 1056:454 Life Sciences 1036: 1035: 411:and receiving an 236: 235: 230: 223: 211: 167:C. difficile 16:(Redirected from 5496: 5449: 5448: 5436: 5435: 5426: 5425: 5413: 5412: 5400: 5399: 5387: 5386: 5374: 5373: 5361: 5360: 5359: 5346: 5345: 5344: 5318: 5317: 5305: 5304: 5292: 5291: 5279: 5278: 5266: 5265: 5253: 5252: 5240: 5239: 5238: 5208: 5207: 5127:Mycoplasmataceae 5123: 5122: 5103:Finegoldia magna 4976: 4975: 4960: 4959: 4858:S. saprophyticus 4786: 4785: 4775: 4774: 4571: 4570: 4472: 4471: 4463: 4462: 4452: 4451: 4437: 4436: 4396: 4389: 4382: 4373: 4372: 4340: 4339: 4329: 4319: 4295: 4286: 4285: 4275: 4265: 4241: 4235: 4218: 4212: 4211: 4201: 4191: 4159: 4153: 4152: 4142: 4102: 4096: 4095: 4085: 4075: 4047: 4041: 4040: 4030: 4006: 4000: 3999: 3989: 3979: 3955: 3949: 3948: 3946: 3944: 3910: 3902: 3896: 3895: 3885: 3837: 3831: 3830: 3812: 3788: 3782: 3781: 3771: 3747: 3741: 3740: 3730: 3698: 3692: 3691: 3663: 3657: 3656: 3638: 3620: 3611: 3605: 3604: 3586: 3562: 3553: 3552: 3550: 3548: 3542: 3536:. Archived from 3531: 3523: 3517: 3516: 3506: 3495:10.5009/gnl18071 3470: 3464: 3463: 3453: 3421: 3415: 3414: 3404: 3372: 3366: 3365: 3355: 3323: 3317: 3316: 3280: 3271: 3270: 3260: 3235:(5): e00730–20. 3220: 3214: 3213: 3195: 3172:Gastroenterology 3166: 3160: 3159: 3149: 3139: 3111: 3102: 3101: 3091: 3076:Gastroenterology 3067: 3061: 3060: 3050: 3040: 3031:(9): 1552–1554. 3016: 3010: 3009: 2999: 2989: 2957: 2951: 2950: 2940: 2916: 2910: 2909: 2899: 2889: 2865: 2856: 2855: 2845: 2835: 2811: 2805: 2804: 2802: 2800: 2785: 2774: 2773: 2765: 2759: 2758: 2756: 2754: 2732: 2726: 2725: 2715: 2691: 2685: 2684: 2674: 2642: 2633: 2632: 2630: 2628: 2622: 2611: 2603: 2597: 2596: 2594: 2592: 2573: 2567: 2566: 2564: 2562: 2520: 2512: 2506: 2505: 2503: 2501: 2482: 2476: 2475: 2465: 2433: 2427: 2426: 2416: 2406: 2378: 2372: 2371: 2361: 2337: 2331: 2330: 2312: 2288: 2279: 2278: 2276: 2274: 2232: 2225: 2219: 2213: 2212: 2202: 2170: 2164: 2163: 2153: 2136:(3): 1026–1031. 2121: 2115: 2114: 2104: 2094: 2070: 2064: 2063: 2053: 2021: 2015: 2014: 2004: 1994: 1962: 1956: 1955: 1927: 1918: 1917: 1907: 1890:(9): 3140–3143. 1875: 1869: 1868: 1858: 1848: 1816: 1810: 1809: 1773: 1764: 1763: 1735: 1729: 1728: 1700: 1694: 1693: 1683: 1673: 1649: 1643: 1642: 1632: 1615:(5): 2326–2332. 1600: 1594: 1593: 1583: 1547: 1541: 1540: 1530: 1498: 1492: 1491: 1489: 1487: 1468: 1462: 1461: 1445: 1435: 1422: 1421: 1411: 1379: 1373: 1372: 1344: 1338: 1337: 1335: 1333: 1318: 1312: 1311: 1301: 1284:(8): 1873–1885. 1278:Cancer Discovery 1269: 1263: 1262: 1260: 1258: 1234: 1228: 1227: 1225: 1223: 1195: 1189: 1188: 1164: 1044:Sanger Institute 1011: 989: 976: 972: 662:fecal-oral route 550:ADP-ribosylation 401:fluoroquinolones 297: 296: 293: 292: 289: 286: 282: 281: 278: 229: 217: 209: 187: 94: 93: 75: 55: 41: 40: 21: 5504: 5503: 5499: 5498: 5497: 5495: 5494: 5493: 5459: 5458: 5457: 5452: 5444: 5439: 5431: 5429: 5421: 5416: 5408: 5403: 5395: 5390: 5382: 5377: 5369: 5364: 5355: 5354: 5349: 5340: 5339: 5334: 5321: 5313: 5308: 5300: 5295: 5287: 5282: 5274: 5269: 5261: 5256: 5248: 5243: 5234: 5233: 5228: 5215: 5205: 5196: 5169: 5108: 5085: 5047: 5015: 4941: 4912: 4900:Bacillus cereus 4865: 4821: 4766: 4754: 4710: 4677: 4652: 4620: 4614:Rheumatic fever 4556: 4498: 4443: 4441:Lactobacillales 4426: 4400: 4359:Type strain of 4349: 4344: 4343: 4296: 4289: 4242: 4238: 4232:Wayback Machine 4221:Scientists map 4219: 4215: 4160: 4156: 4103: 4099: 4048: 4044: 4007: 4003: 3956: 3952: 3942: 3940: 3903: 3899: 3838: 3834: 3789: 3785: 3748: 3744: 3699: 3695: 3664: 3660: 3618: 3612: 3608: 3563: 3556: 3546: 3544: 3540: 3529: 3525: 3524: 3520: 3471: 3467: 3436:(12): e45–e80. 3422: 3418: 3373: 3369: 3324: 3320: 3281: 3274: 3221: 3217: 3167: 3163: 3112: 3105: 3068: 3064: 3017: 3013: 2958: 2954: 2917: 2913: 2866: 2859: 2812: 2808: 2798: 2796: 2787: 2786: 2777: 2766: 2762: 2752: 2750: 2733: 2729: 2692: 2688: 2643: 2636: 2626: 2624: 2620: 2609: 2605: 2604: 2600: 2590: 2588: 2575: 2574: 2570: 2560: 2558: 2513: 2509: 2499: 2497: 2484: 2483: 2479: 2434: 2430: 2379: 2375: 2338: 2334: 2289: 2282: 2272: 2270: 2227: 2226: 2222: 2216: 2171: 2167: 2122: 2118: 2071: 2067: 2022: 2018: 1963: 1959: 1928: 1921: 1876: 1872: 1817: 1813: 1774: 1767: 1736: 1732: 1701: 1697: 1650: 1646: 1601: 1597: 1548: 1544: 1499: 1495: 1485: 1483: 1470: 1469: 1465: 1458: 1436: 1425: 1380: 1376: 1349:JAMA Pediatrics 1345: 1341: 1331: 1329: 1320: 1319: 1315: 1270: 1266: 1256: 1254: 1241: 1235: 1231: 1221: 1219: 1196: 1192: 1165: 1161: 1156: 1151: 1141: 1110: 1091: 1065:Researchers at 1009: 985: 971: 932: 920: 840: 831: 809:17 helper cells 808: 792: 776: 774:Pathophysiology 764:bowel movements 752: 714: 706:GI disturbances 690:Crohn's disease 643: 599:fluoroquinolone 597:, resistant to 580: 538:toxic megacolon 485: 443: 409:stool softeners 283: 275: 271: 192: 189: 183: 170: 88: 37: 28: 23: 22: 15: 12: 11: 5: 5502: 5492: 5491: 5486: 5481: 5476: 5471: 5454: 5453: 5451: 5450: 5437: 5427: 5414: 5401: 5388: 5375: 5362: 5347: 5331: 5329: 5323: 5322: 5320: 5319: 5306: 5293: 5280: 5267: 5254: 5241: 5225: 5223: 5217: 5216: 5202: 5201: 5198: 5197: 5195: 5194: 5193: 5192: 5179: 5177: 5171: 5170: 5168: 5167: 5166: 5165: 5153: 5146: 5145: 5144: 5131: 5129: 5120: 5114: 5113: 5110: 5109: 5107: 5106: 5098: 5096: 5087: 5086: 5084: 5083: 5082: 5081: 5068: 5066: 5058:Clostridioides 5053: 5052: 5049: 5048: 5046: 5045: 5044: 5043: 5038: 5025: 5023: 5017: 5016: 5014: 5013: 5012: 5011: 4999: 4998: 4997: 4984: 4982: 4973: 4957: 4951: 4950: 4947: 4946: 4943: 4942: 4940: 4939: 4938: 4937: 4924: 4922: 4914: 4913: 4911: 4910: 4909: 4908: 4906:Food poisoning 4896: 4895: 4894: 4881: 4879: 4871: 4870: 4867: 4866: 4864: 4863: 4862: 4861: 4849: 4848: 4847: 4844:S. epidermidis 4831: 4829: 4823: 4822: 4820: 4819: 4818: 4817: 4812: 4807: 4794: 4792: 4783: 4780:Staphylococcus 4772: 4760: 4759: 4756: 4755: 4753: 4752: 4745: 4744: 4743: 4726: 4724: 4716: 4715: 4712: 4711: 4709: 4708: 4697: 4691: 4689: 4683: 4682: 4679: 4678: 4676: 4675: 4674: 4673: 4660: 4658: 4654: 4653: 4651: 4650: 4649: 4648: 4630: 4628: 4622: 4621: 4619: 4618: 4617: 4616: 4611: 4606: 4601: 4596: 4579: 4577: 4568: 4562: 4561: 4558: 4557: 4555: 4554: 4546: 4539: 4532: 4525: 4518: 4506: 4504: 4500: 4499: 4497: 4496: 4495: 4494: 4481: 4479: 4469: 4460: 4449: 4434: 4428: 4427: 4425: 4424: 4415: 4399: 4398: 4391: 4384: 4376: 4370: 4369: 4356: 4348: 4347:External links 4345: 4342: 4341: 4287: 4250:Genome Biology 4236: 4213: 4154: 4097: 4042: 4001: 3950: 3919:(1): 118–125. 3897: 3832: 3803:(6): 710–717. 3783: 3742: 3713:(3): 481–494. 3693: 3658: 3606: 3554: 3518: 3465: 3416: 3387:(5): 440–447. 3367: 3318: 3291:(7): 526–536. 3272: 3215: 3161: 3103: 3062: 3011: 2952: 2931:(7): 571–576. 2911: 2857: 2806: 2775: 2760: 2727: 2713:10.1086/655692 2706:(5): 577–582. 2686: 2657:(1): 166–180. 2634: 2598: 2568: 2507: 2477: 2428: 2373: 2359:10.1086/502600 2352:(8): 672–675. 2332: 2280: 2220: 2214: 2165: 2116: 2065: 2016: 1957: 1919: 1870: 1831:(11): e78445. 1811: 1784:(4): 642–650. 1765: 1746:(4): 204–210. 1730: 1711:(3): 678–684. 1695: 1644: 1595: 1542: 1493: 1463: 1456: 1423: 1394:(5): 285–298. 1374: 1339: 1313: 1264: 1229: 1190: 1179:(2): 390–402. 1158: 1157: 1155: 1152: 1140: 1137: 1117:bacteriophages 1109: 1106: 1090: 1087: 1034: 1033: 1030: 1024: 1023: 1020: 1013: 1012: 1007: 1001: 1000: 997: 991: 990: 983: 970: 967: 931: 928: 919: 916: 839: 836: 830: 827: 806: 791: 788: 775: 772: 768:abdominal pain 751: 748: 713: 710: 686:food poisoning 642: 639: 579: 576: 484: 483:Human pathogen 481: 454:Clostridioides 442: 439: 435:laxative abuse 431:food poisoning 405:cephalosporins 391:(CDI), namely 311:Clostridioides 234: 233: 232: 231: 224: 212: 201: 200: 194: 193: 190: 179: 178: 172: 171: 164: 162: 158: 157: 154:Clostridioides 150: 146: 145: 140: 136: 135: 130: 126: 125: 120: 116: 115: 110: 106: 105: 100: 96: 95: 82: 81: 77: 76: 68: 67: 57: 56: 48: 47: 26: 9: 6: 4: 3: 2: 5501: 5490: 5487: 5485: 5482: 5480: 5477: 5475: 5472: 5470: 5467: 5466: 5464: 5447: 5442: 5438: 5434: 5428: 5424: 5419: 5415: 5411: 5406: 5402: 5398: 5393: 5389: 5385: 5380: 5376: 5372: 5367: 5363: 5358: 5352: 5348: 5343: 5337: 5333: 5332: 5330: 5328: 5324: 5316: 5311: 5307: 5303: 5298: 5294: 5290: 5285: 5281: 5277: 5272: 5268: 5264: 5259: 5255: 5251: 5246: 5242: 5237: 5231: 5227: 5226: 5224: 5222: 5218: 5214: 5209: 5191: 5188: 5187: 5186: 5185: 5181: 5180: 5178: 5176: 5172: 5164: 5161: 5160: 5159: 5158: 5154: 5152: 5151: 5147: 5143: 5140: 5139: 5138: 5137: 5133: 5132: 5130: 5128: 5124: 5121: 5119: 5115: 5105: 5104: 5100: 5099: 5097: 5094: 5093: 5088: 5080: 5077: 5076: 5075: 5074: 5070: 5069: 5067: 5064: 5060: 5059: 5054: 5042: 5039: 5037: 5034: 5033: 5032: 5031: 5027: 5026: 5024: 5022: 5018: 5010: 5007: 5006: 5005: 5004: 5000: 4996: 4993: 4992: 4991: 4990: 4986: 4985: 4983: 4981: 4977: 4974: 4971: 4967: 4966: 4961: 4958: 4956: 4952: 4936: 4933: 4932: 4931: 4930: 4926: 4925: 4923: 4921: 4920: 4915: 4907: 4904: 4903: 4902: 4901: 4897: 4893: 4890: 4889: 4888: 4887: 4883: 4882: 4880: 4878: 4877: 4872: 4860: 4859: 4855: 4854: 4853: 4850: 4846: 4845: 4841: 4840: 4839: 4837: 4833: 4832: 4830: 4828: 4824: 4816: 4813: 4811: 4808: 4806: 4803: 4802: 4801: 4800: 4796: 4795: 4793: 4791: 4787: 4784: 4782: 4781: 4776: 4773: 4770: 4765: 4761: 4751: 4750: 4746: 4742: 4739: 4738: 4737: 4736: 4731: 4728: 4727: 4725: 4723: 4722: 4717: 4707: 4706: 4701: 4698: 4696: 4693: 4692: 4690: 4688: 4684: 4672: 4669: 4668: 4667: 4666: 4662: 4661: 4659: 4655: 4647: 4644: 4643: 4642: 4641: 4640:S. agalactiae 4636: 4632: 4631: 4629: 4627: 4623: 4615: 4612: 4610: 4607: 4605: 4604:Scarlet fever 4602: 4600: 4597: 4595: 4592: 4591: 4590: 4589: 4585:susceptible: 4584: 4581: 4580: 4578: 4576: 4572: 4569: 4567: 4563: 4553: 4551: 4547: 4545: 4544: 4540: 4538: 4537: 4533: 4531: 4530: 4526: 4524: 4523: 4519: 4517: 4516: 4511: 4508: 4507: 4505: 4501: 4493: 4490: 4489: 4488: 4487: 4486:S. pneumoniae 4483: 4482: 4480: 4477: 4473: 4470: 4468: 4464: 4461: 4459: 4458: 4457:Streptococcus 4453: 4450: 4447: 4442: 4438: 4435: 4433: 4429: 4423: 4419: 4416: 4414: 4410: 4406: 4403: 4402: 4397: 4392: 4390: 4385: 4383: 4378: 4377: 4374: 4367: 4363: 4362: 4357: 4354: 4351: 4350: 4337: 4333: 4328: 4323: 4318: 4313: 4309: 4305: 4301: 4294: 4292: 4283: 4279: 4274: 4269: 4264: 4259: 4255: 4251: 4247: 4240: 4233: 4229: 4226: 4224: 4217: 4209: 4205: 4200: 4195: 4190: 4185: 4181: 4177: 4173: 4169: 4165: 4158: 4150: 4146: 4141: 4136: 4132: 4128: 4124: 4120: 4116: 4112: 4108: 4101: 4093: 4089: 4084: 4079: 4074: 4069: 4065: 4061: 4057: 4053: 4052:Prystajecky N 4046: 4038: 4034: 4029: 4024: 4020: 4016: 4012: 4005: 3997: 3993: 3988: 3983: 3978: 3973: 3969: 3965: 3961: 3954: 3938: 3934: 3930: 3926: 3922: 3918: 3914: 3909: 3901: 3893: 3889: 3884: 3879: 3875: 3871: 3867: 3863: 3859: 3855: 3851: 3847: 3843: 3836: 3828: 3824: 3820: 3816: 3811: 3806: 3802: 3798: 3794: 3787: 3779: 3775: 3770: 3765: 3761: 3757: 3753: 3746: 3738: 3734: 3729: 3724: 3720: 3716: 3712: 3708: 3704: 3697: 3689: 3685: 3681: 3677: 3673: 3669: 3662: 3654: 3650: 3646: 3642: 3637: 3632: 3628: 3624: 3617: 3610: 3602: 3598: 3594: 3590: 3585: 3580: 3576: 3572: 3568: 3561: 3559: 3539: 3535: 3528: 3522: 3514: 3510: 3505: 3500: 3496: 3492: 3488: 3484: 3483:Gut and Liver 3480: 3478: 3469: 3461: 3457: 3452: 3447: 3443: 3439: 3435: 3431: 3427: 3420: 3412: 3408: 3403: 3398: 3394: 3390: 3386: 3382: 3378: 3371: 3363: 3359: 3354: 3349: 3345: 3341: 3338:(7): e1–e48. 3337: 3333: 3329: 3322: 3314: 3310: 3306: 3302: 3298: 3294: 3290: 3286: 3279: 3277: 3268: 3264: 3259: 3254: 3250: 3246: 3242: 3238: 3234: 3230: 3226: 3219: 3211: 3207: 3203: 3199: 3194: 3189: 3185: 3181: 3177: 3173: 3165: 3157: 3153: 3148: 3143: 3138: 3133: 3129: 3125: 3121: 3119: 3110: 3108: 3099: 3095: 3090: 3085: 3081: 3077: 3073: 3066: 3058: 3054: 3049: 3044: 3039: 3034: 3030: 3026: 3022: 3015: 3007: 3003: 2998: 2993: 2988: 2983: 2979: 2975: 2971: 2969: 2965: 2956: 2948: 2944: 2939: 2934: 2930: 2926: 2922: 2915: 2907: 2903: 2898: 2893: 2888: 2883: 2879: 2875: 2871: 2864: 2862: 2853: 2849: 2844: 2839: 2834: 2829: 2825: 2821: 2817: 2810: 2794: 2790: 2784: 2782: 2780: 2771: 2764: 2748: 2744: 2743: 2738: 2731: 2723: 2719: 2714: 2709: 2705: 2701: 2697: 2690: 2682: 2678: 2673: 2668: 2664: 2660: 2656: 2652: 2648: 2641: 2639: 2619: 2615: 2608: 2602: 2586: 2582: 2578: 2572: 2556: 2552: 2548: 2544: 2540: 2536: 2532: 2528: 2524: 2519: 2511: 2495: 2491: 2487: 2481: 2473: 2469: 2464: 2459: 2455: 2451: 2447: 2443: 2439: 2432: 2424: 2420: 2415: 2410: 2405: 2400: 2396: 2392: 2388: 2386: 2377: 2369: 2365: 2360: 2355: 2351: 2347: 2343: 2336: 2328: 2324: 2320: 2316: 2311: 2306: 2302: 2298: 2294: 2287: 2285: 2268: 2264: 2260: 2256: 2252: 2248: 2244: 2240: 2236: 2231: 2224: 2218: 2210: 2206: 2201: 2196: 2192: 2188: 2184: 2180: 2176: 2169: 2161: 2157: 2152: 2147: 2143: 2139: 2135: 2131: 2127: 2120: 2112: 2108: 2103: 2098: 2093: 2088: 2084: 2080: 2076: 2069: 2061: 2057: 2052: 2047: 2043: 2039: 2035: 2031: 2027: 2020: 2012: 2008: 2003: 1998: 1993: 1988: 1984: 1980: 1976: 1974: 1970: 1961: 1953: 1949: 1945: 1941: 1937: 1933: 1926: 1924: 1915: 1911: 1906: 1901: 1897: 1893: 1889: 1885: 1881: 1874: 1866: 1862: 1857: 1852: 1847: 1842: 1838: 1834: 1830: 1826: 1822: 1815: 1807: 1803: 1799: 1795: 1791: 1787: 1783: 1779: 1772: 1770: 1761: 1757: 1753: 1749: 1745: 1741: 1734: 1726: 1722: 1718: 1714: 1710: 1706: 1699: 1691: 1687: 1682: 1677: 1672: 1667: 1664:(5): e39029. 1663: 1659: 1655: 1648: 1640: 1636: 1631: 1626: 1622: 1618: 1614: 1610: 1606: 1599: 1591: 1587: 1582: 1577: 1573: 1569: 1566:(4): ofx171. 1565: 1561: 1557: 1555: 1546: 1538: 1534: 1529: 1524: 1520: 1516: 1512: 1508: 1504: 1497: 1481: 1477: 1473: 1467: 1459: 1453: 1449: 1444: 1443: 1434: 1432: 1430: 1428: 1419: 1415: 1410: 1405: 1401: 1397: 1393: 1389: 1385: 1378: 1370: 1366: 1362: 1358: 1354: 1350: 1343: 1327: 1323: 1317: 1309: 1305: 1300: 1295: 1291: 1287: 1283: 1279: 1275: 1268: 1252: 1248: 1244: 1239: 1233: 1217: 1213: 1209: 1205: 1203: 1194: 1186: 1182: 1178: 1174: 1170: 1163: 1159: 1149: 1147: 1136: 1134: 1130: 1126: 1122: 1118: 1115: 1108:Bacteriophage 1105: 1103: 1099: 1095: 1086: 1084: 1079: 1076: 1072: 1068: 1063: 1061: 1057: 1053: 1049: 1045: 1041: 1031: 1029: 1025: 1021: 1019: 1014: 1008: 1006: 1002: 998: 996: 992: 988: 984: 981: 977: 966: 964: 959: 955: 954:BI/NAP1/027. 953: 949: 945: 941: 937: 927: 924: 915: 913: 908: 906: 901: 899: 895: 890: 888: 887: 882: 877: 874: 870: 866: 861: 858: 854: 853:metronidazole 850: 846: 835: 826: 823: 819: 814: 810: 802: 797: 787: 785: 780: 771: 769: 765: 761: 757: 747: 745: 740: 736: 732: 728: 725: 720: 718: 709: 707: 703: 699: 695: 691: 687: 682: 680: 679:C. diffiicile 676: 671: 667: 663: 659: 652: 649:Gram-stained 647: 638: 636: 632: 631:disinfectants 628: 623: 621: 616: 612: 608: 604: 603:ciprofloxacin 600: 596: 592: 588: 585:treatment of 584: 575: 573: 571: 566: 565:hyaluronidase 561: 559: 555: 551: 547: 543: 539: 535: 531: 529: 524: 520: 516: 514: 509: 505: 503: 498: 494: 490: 480: 478: 474: 470: 466: 465: 460: 456: 455: 450: 449: 438: 436: 432: 428: 424: 420: 416: 414: 410: 406: 402: 398: 394: 390: 388: 382: 378: 374: 370: 366: 364: 360: 356: 355:enterotoxin A 352: 348: 344: 340: 336: 332: 328: 327:Gram staining 324: 320: 316: 312: 308: 304: 301: 300:Gram-positive 298:), and is a 295: 269: 268: 263: 262: 257: 253: 249: 246: 242: 241: 228: 225: 221: 216: 213: 208: 205: 204: 202: 199: 195: 188: 186: 180: 177: 176:Binomial name 173: 169: 168: 163: 160: 159: 156: 155: 151: 148: 147: 144: 141: 138: 137: 134: 133:Eubacteriales 131: 128: 127: 124: 121: 118: 117: 114: 111: 108: 107: 104: 101: 98: 97: 92: 87: 83: 78: 74: 69: 66: 62: 58: 54: 49: 46: 42: 39: 35: 30: 19: 5326: 5220: 5182: 5155: 5148: 5134: 5101: 5090: 5072: 5071: 5056: 5036:Gas gangrene 5028: 5020: 5001: 4987: 4979: 4963: 4927: 4917: 4898: 4884: 4874: 4856: 4851: 4842: 4834: 4797: 4778: 4747: 4733: 4721:Enterococcus 4719: 4703: 4663: 4638: 4586: 4550:S. anginosus 4549: 4541: 4536:S. sanguinis 4534: 4527: 4520: 4513: 4484: 4455: 4365: 4360: 4307: 4303: 4256:(12): R118. 4253: 4249: 4239: 4223:C. difficile 4222: 4216: 4171: 4167: 4157: 4114: 4110: 4100: 4063: 4059: 4045: 4018: 4014: 4004: 3967: 3963: 3953: 3941:. Retrieved 3916: 3912: 3900: 3849: 3845: 3835: 3800: 3796: 3786: 3762:(1): 12–18. 3759: 3755: 3745: 3710: 3706: 3696: 3671: 3667: 3661: 3626: 3622: 3609: 3574: 3570: 3545:. Retrieved 3538:the original 3533: 3521: 3489:(1): 16–24. 3486: 3482: 3476: 3468: 3433: 3429: 3419: 3384: 3380: 3370: 3335: 3331: 3321: 3288: 3284: 3232: 3228: 3218: 3193:11343/289863 3175: 3171: 3164: 3127: 3123: 3117: 3079: 3075: 3065: 3028: 3024: 3014: 2977: 2973: 2968:C. difficile 2967: 2963: 2955: 2928: 2924: 2914: 2877: 2873: 2823: 2819: 2809: 2797:. Retrieved 2769: 2763: 2753:February 25, 2751:. Retrieved 2740: 2730: 2703: 2699: 2689: 2654: 2650: 2625:. Retrieved 2613: 2601: 2589:. Retrieved 2580: 2571: 2559:. Retrieved 2526: 2522: 2510: 2500:November 22, 2498:. Retrieved 2489: 2480: 2445: 2441: 2431: 2394: 2390: 2384: 2376: 2349: 2345: 2335: 2300: 2296: 2271:. Retrieved 2238: 2234: 2223: 2217: 2182: 2178: 2168: 2133: 2129: 2119: 2082: 2078: 2068: 2033: 2029: 2019: 1982: 1978: 1973:C. difficile 1972: 1968: 1960: 1935: 1931: 1887: 1883: 1873: 1828: 1824: 1814: 1781: 1777: 1743: 1739: 1733: 1708: 1704: 1698: 1661: 1657: 1647: 1612: 1608: 1598: 1563: 1559: 1553: 1545: 1510: 1506: 1496: 1484:. Retrieved 1475: 1466: 1441: 1391: 1387: 1377: 1352: 1348: 1342: 1330:. Retrieved 1316: 1281: 1277: 1267: 1255:. Retrieved 1237: 1232: 1222:December 15, 1220:. Retrieved 1211: 1207: 1201: 1193: 1176: 1172: 1168: 1162: 1145: 1129:C. difficile 1128: 1121:C. difficile 1120: 1111: 1102:C. difficile 1101: 1097: 1093: 1092: 1083:C. difficile 1082: 1080: 1075:C. difficile 1074: 1064: 1048:C. difficile 1047: 1040:C. difficile 1039: 1037: 960: 956: 952:C. difficile 951: 936:C. difficile 935: 933: 923:C. difficile 922: 921: 912:C. difficile 911: 909: 902: 898:bezlotoxumab 891: 884: 881:C. difficile 880: 878: 873:C. difficile 872: 869:C. difficile 868: 862: 845:C. difficile 844: 841: 832: 813:C. difficile 812: 801:C. difficile 800: 796:C. difficile 795: 793: 784:C. difficile 783: 779:C. difficile 778: 777: 756:C. difficile 755: 754:Symptoms of 753: 744:C. difficile 743: 739:C. difficile 738: 735:C. difficile 734: 730: 729: 723: 721: 716: 715: 702:C. difficile 701: 698:C. difficile 697: 694:C. difficile 693: 683: 678: 670:C. difficile 669: 668:spores, and 666:C. difficile 665: 657: 656: 650: 641:Transmission 627:C. difficile 626: 624: 620:C. difficile 619: 607:levofloxacin 595:C. difficile 594: 586: 581: 569: 562: 554:binary toxin 528:C. difficile 527: 523:inflammation 513:C. difficile 512: 502:C. difficile 501: 489:C. difficile 488: 486: 476: 472: 468: 462: 458: 452: 446: 444: 427:C. difficile 426: 418: 417: 387:C. difficile 386: 381:C. difficile 380: 368: 367: 343:C. difficile 342: 331:C. difficile 330: 310: 266: 265: 261:C. difficile 260: 259: 256:colon cancer 247: 239: 238: 237: 226: 214: 206: 184: 182: 166: 165: 153: 61:C. difficile 60: 44: 38: 29: 5351:Wikispecies 5190:Erysipeloid 4965:Clostridium 4935:Listeriosis 4838:susceptible 4588:S. pyogenes 4543:S. sobrinus 4478:susceptible 4066:: 8207418. 4050:Jassem AN, 3674:(1): 8–12. 3475:"Recurrent 2980:: 169–175. 2397:: 8414257. 1476:www.cdc.gov 1257:November 8, 1202:Clostridium 1018:chromosomes 1005:Genome size 894:fidaxomicin 857:fidaxomicin 497:enterotoxin 487:Pathogenic 464:Clostridium 448:Clostridium 397:clindamycin 359:cytotoxin B 323:pleomorphic 5463:Categories 5118:Mollicutes 5092:Finegoldia 5021:nonmotile: 4955:Clostridia 4836:novobiocin 4764:Bacillales 4609:Erysipelas 4583:bacitracin 3970:(1): 1–6. 3852:(1): 755. 2970:infection" 2273:October 8, 2085:(5): 134. 1975:Infection" 1355:(6): 592. 1332:August 29, 1154:References 1052:sequencing 1016:Number of 918:Prevention 849:vancomycin 712:Host range 583:Antibiotic 393:vancomycin 335:blood agar 123:Clostridia 65:agar plate 5489:Anaerobes 5236:Q56290719 5065:-forming) 4972:-forming) 4799:S. aureus 4657:ungrouped 4635:CAMP test 4529:S. oralis 4522:S. mutans 4405:Bacillota 3964:Gut Liver 3943:March 20, 3874:2041-1723 3653:239473944 3547:April 28, 3249:1098-5522 3210:231611318 2826:: 16020. 2543:0893-8512 1938:: 95–99. 1806:211074075 1486:March 10, 1214:(1): 84. 1133:prophages 1114:temperate 1089:Epigenome 982:genome ID 963:trehalose 838:Treatment 829:Diagnosis 508:cytotoxin 389:infection 315:anaerobic 313:spp. are 252:bacterium 161:Species: 113:Bacillota 5397:10917971 5336:Wikidata 5263:52503553 5230:Wikidata 4995:Botulism 4919:Listeria 4876:Bacillus 4515:S. mitis 4476:optochin 4336:24808893 4282:23259504 4228:Archived 4208:20368420 4149:29310122 4092:27366181 4037:29505879 3996:24516694 3937:Archived 3933:23086451 3892:33531483 3819:29528385 3778:33520564 3737:32632582 3688:25982915 3645:34678515 3601:54629762 3593:23439232 3513:30400734 3460:29053792 3411:21844027 3362:29462280 3313:23376891 3305:19528959 3267:33649048 3202:33444574 3156:37389232 3147:10303512 3098:33253683 3057:22787196 3006:28765714 2947:38508330 2925:Am J Med 2906:22752867 2852:27158839 2793:Archived 2747:Archived 2722:20642351 2681:31768029 2627:June 18, 2618:Archived 2585:Archived 2561:March 4, 2555:Archived 2551:38421181 2494:Archived 2490:BBC News 2472:31611365 2423:29682562 2368:16156321 2327:14818750 2319:16322602 2267:Archived 2263:52297840 2209:15353562 2111:27153087 2060:27902180 2011:29473021 1952:27370902 1932:Anaerobe 1914:28891789 1865:24265690 1825:PLOS ONE 1798:32042128 1690:37323360 1681:10266117 1639:23478961 1590:29732377 1537:24066741 1480:Archived 1418:34837014 1369:23733223 1326:Archived 1308:35678528 1251:Archived 1216:Archived 1060:Illumina 948:ribotype 818:microRNA 760:diarrhea 558:AB toxin 519:diarrhea 441:Taxonomy 373:pathogen 347:catalase 198:Synonyms 139:Family: 109:Phylum: 103:Bacteria 99:Domain: 5446:5256524 5384:3226608 5342:Q310543 5315:5256524 5276:9290075 5245:BacDive 5009:Tetanus 4980:motile: 4892:Anthrax 4432:Bacilli 4327:4009436 4310:: 184. 4273:4056369 4199:2867753 4176:Bibcode 4140:5984069 4119:Bibcode 4083:4904575 3987:3916678 3883:7854624 3854:Bibcode 3827:3841585 3769:7817514 3728:7452994 3504:6346998 3451:5850553 3402:3156139 3353:6018983 3258:8091099 3048:3428380 2997:5525456 2897:3388017 2843:5453186 2799:May 22, 2672:6925328 2591:May 22, 2463:7187568 2414:5841113 2243:Bibcode 2160:7883950 2102:4885049 2051:5244501 2002:5809512 1905:5817221 1856:3827041 1833:Bibcode 1760:2911306 1725:2387993 1630:3632900 1581:5903408 1528:3868928 1409:9018519 1299:9357196 999:haploid 946:and as 930:Strains 865:relapse 724:C. diff 651:C. diff 615:Atlanta 587:C. diff 572:-cresol 534:colitis 530:colitis 515:toxin B 504:toxin A 469:C. diff 303:species 267:C. diff 250:) is a 222:, 1938 149:Genus: 129:Order: 119:Class: 5430:NZOR: 5410:960739 5371:995330 4334:  4324:  4280:  4270:  4225:strain 4206:  4196:  4147:  4137:  4111:Nature 4090:  4080:  4035:  3994:  3984:  3931:  3890:  3880:  3872:  3825:  3817:  3776:  3766:  3735:  3725:  3686:  3651:  3643:  3599:  3591:  3511:  3501:  3458:  3448:  3409:  3399:  3360:  3350:  3311:  3303:  3265:  3255:  3247:  3208:  3200:  3154:  3144:  3096:  3055:  3045:  3004:  2994:  2945:  2904:  2894:  2850:  2840:  2720:  2679:  2669:  2549:  2541:  2470:  2460:  2421:  2411:  2366:  2325:  2317:  2261:  2235:Nature 2207:  2200:515256 2197:  2158:  2151:441436 2148:  2109:  2099:  2079:Toxins 2058:  2048:  2009:  1999:  1985:: 29. 1950:  1912:  1902:  1863:  1853:  1804:  1796:  1758:  1723:  1688:  1678:  1658:Cureus 1637:  1627:  1588:  1578:  1535:  1525:  1454:  1416:  1406:  1367:  1306:  1296:  1071:genome 1010:4.3 Mb 995:Ploidy 969:Genome 635:bleach 506:) and 493:toxins 363:spores 349:- and 339:oxygen 319:motile 220:Prévot 5392:IRMNG 5063:spore 4970:spore 4552:group 4407:(low- 4364:, Bac 3823:S2CID 3649:S2CID 3619:(PDF) 3597:S2CID 3541:(PDF) 3530:(PDF) 3309:S2CID 3206:S2CID 2621:(PDF) 2610:(PDF) 2448:(1). 2323:S2CID 2259:S2CID 1802:S2CID 1236:Page 546:actin 423:colon 413:enema 307:spore 264:, or 5418:LPSN 5405:ITIS 5379:GBIF 5302:1496 5297:NCBI 5284:LPSN 5271:GBIF 5250:2582 4815:MRSA 4769:Cat+ 4446:Cat- 4366:Dive 4332:PMID 4278:PMID 4204:PMID 4145:PMID 4088:PMID 4064:2016 4033:PMID 3992:PMID 3945:2024 3929:PMID 3888:PMID 3870:ISSN 3815:PMID 3774:PMID 3733:PMID 3684:PMID 3641:PMID 3589:PMID 3549:2018 3509:PMID 3456:PMID 3407:PMID 3358:PMID 3301:PMID 3263:PMID 3245:ISSN 3198:PMID 3152:PMID 3094:PMID 3053:PMID 3002:PMID 2943:PMID 2902:PMID 2848:PMID 2801:2017 2755:2015 2718:PMID 2677:PMID 2629:2018 2593:2017 2563:2024 2547:PMID 2539:ISSN 2502:2023 2468:PMID 2419:PMID 2395:2018 2364:PMID 2315:PMID 2275:2018 2205:PMID 2156:PMID 2107:PMID 2056:PMID 2007:PMID 1948:PMID 1910:PMID 1861:PMID 1794:PMID 1756:PMID 1721:PMID 1686:PMID 1635:PMID 1586:PMID 1533:PMID 1488:2020 1452:ISBN 1450:–4. 1414:PMID 1365:PMID 1334:2022 1304:PMID 1259:2022 1224:2018 1143:See 1058:and 1032:2005 980:NCBI 794:The 605:and 570:para 521:and 403:and 245:syn. 5366:EoL 5258:EoL 4827:Cg- 4790:Cg+ 4732:+: 4730:BEA 4702:+: 4700:BEA 4637:+: 4409:G+C 4322:PMC 4312:doi 4268:PMC 4258:doi 4194:PMC 4184:doi 4172:107 4135:PMC 4127:doi 4115:553 4078:PMC 4068:doi 4023:doi 3982:PMC 3972:doi 3921:doi 3878:PMC 3862:doi 3805:doi 3764:PMC 3723:PMC 3715:doi 3676:doi 3631:doi 3579:doi 3575:108 3499:PMC 3491:doi 3446:PMC 3438:doi 3397:PMC 3389:doi 3348:PMC 3340:doi 3293:doi 3253:PMC 3237:doi 3188:hdl 3180:doi 3176:160 3142:PMC 3132:doi 3084:doi 3080:160 3043:PMC 3033:doi 2992:PMC 2982:doi 2933:doi 2929:137 2892:PMC 2882:doi 2838:PMC 2828:doi 2708:doi 2667:PMC 2659:doi 2531:doi 2458:PMC 2450:doi 2409:PMC 2399:doi 2354:doi 2305:doi 2301:353 2251:doi 2239:561 2195:PMC 2187:doi 2146:PMC 2138:doi 2097:PMC 2087:doi 2046:PMC 2038:doi 1997:PMC 1987:doi 1940:doi 1900:PMC 1892:doi 1851:PMC 1841:doi 1786:doi 1748:doi 1744:320 1713:doi 1709:162 1676:PMC 1666:doi 1625:PMC 1617:doi 1576:PMC 1568:doi 1523:PMC 1515:doi 1511:369 1448:322 1404:PMC 1396:doi 1357:doi 1353:167 1294:PMC 1286:doi 1240:on 1181:doi 1171:". 1125:kbp 987:535 613:in 479:). 451:to 433:or 377:CDC 345:is 305:of 5465:: 5443:: 5420:: 5407:: 5394:: 5381:: 5368:: 5353:: 5338:: 5312:: 5299:: 5286:: 5273:: 5260:: 5247:: 5232:: 4512:: 4422:G+ 4420:: 4411:) 4330:. 4320:. 4306:. 4302:. 4290:^ 4276:. 4266:. 4254:13 4252:. 4248:. 4202:. 4192:. 4182:. 4170:. 4166:. 4143:. 4133:. 4125:. 4113:. 4109:. 4086:. 4076:. 4062:. 4058:. 4031:. 4019:24 4017:. 4013:. 3990:. 3980:. 3966:. 3962:. 3935:. 3927:. 3917:17 3915:. 3911:. 3886:. 3876:. 3868:. 3860:. 3850:12 3848:. 3844:. 3821:. 3813:. 3801:12 3799:. 3795:. 3772:. 3760:40 3758:. 3754:. 3731:. 3721:. 3709:. 3705:. 3682:. 3672:46 3670:. 3647:. 3639:. 3627:27 3625:. 3621:. 3595:. 3587:. 3573:. 3569:. 3557:^ 3532:. 3507:. 3497:. 3487:13 3485:. 3481:. 3454:. 3444:. 3434:65 3432:. 3428:. 3405:. 3395:. 3385:53 3383:. 3379:. 3356:. 3346:. 3336:66 3334:. 3330:. 3307:. 3299:. 3287:. 3275:^ 3261:. 3251:. 3243:. 3233:89 3231:. 3227:. 3204:. 3196:. 3186:. 3174:. 3150:. 3140:. 3128:29 3126:. 3122:. 3106:^ 3092:. 3078:. 3074:. 3051:. 3041:. 3029:19 3027:. 3023:. 3000:. 2990:. 2978:10 2976:. 2972:. 2941:. 2927:. 2923:. 2900:. 2890:. 2878:55 2876:. 2872:. 2860:^ 2846:. 2836:. 2822:. 2818:. 2778:^ 2745:. 2739:. 2716:. 2704:51 2702:. 2698:. 2675:. 2665:. 2653:. 2649:. 2637:^ 2612:. 2579:. 2553:. 2545:. 2537:. 2527:37 2525:. 2521:. 2488:. 2466:. 2456:. 2446:64 2444:. 2440:. 2417:. 2407:. 2393:. 2389:. 2362:. 2350:26 2348:. 2344:. 2321:. 2313:. 2299:. 2295:. 2283:^ 2265:. 2257:. 2249:. 2237:. 2233:. 2203:. 2193:. 2183:68 2181:. 2177:. 2154:. 2144:. 2134:95 2132:. 2128:. 2105:. 2095:. 2081:. 2077:. 2054:. 2044:. 2034:66 2032:. 2028:. 2005:. 1995:. 1981:. 1977:. 1946:. 1936:40 1934:. 1922:^ 1908:. 1898:. 1888:67 1886:. 1882:. 1859:. 1849:. 1839:. 1827:. 1823:. 1800:. 1792:. 1780:. 1768:^ 1754:. 1742:. 1719:. 1707:. 1684:. 1674:. 1662:15 1660:. 1656:. 1633:. 1623:. 1613:57 1611:. 1607:. 1584:. 1574:. 1562:. 1558:. 1531:. 1521:. 1509:. 1505:. 1474:. 1426:^ 1412:. 1402:. 1392:20 1390:. 1386:. 1363:. 1351:. 1302:. 1292:. 1282:12 1280:. 1276:. 1249:. 1245:. 1212:61 1210:. 1206:. 1177:49 1175:. 1135:. 1098:A, 1062:. 688:, 637:. 415:. 399:, 395:, 357:, 341:. 329:, 317:, 280:iː 5061:( 4968:( 4771:) 4767:( 4695:D 4687:γ 4626:B 4575:A 4566:β 4467:α 4448:) 4444:( 4395:e 4388:t 4381:v 4338:. 4314:: 4308:5 4284:. 4260:: 4210:. 4186:: 4178:: 4151:. 4129:: 4121:: 4094:. 4070:: 4039:. 4025:: 3998:. 3974:: 3968:8 3947:. 3923:: 3894:. 3864:: 3856:: 3829:. 3807:: 3780:. 3739:. 3717:: 3711:9 3690:. 3678:: 3655:. 3633:: 3603:. 3581:: 3551:. 3515:. 3493:: 3462:. 3440:: 3413:. 3391:: 3364:. 3342:: 3315:. 3295:: 3289:7 3269:. 3239:: 3212:. 3190:: 3182:: 3158:. 3134:: 3100:. 3086:: 3059:. 3035:: 3008:. 2984:: 2949:. 2935:: 2908:. 2884:: 2854:. 2830:: 2824:2 2803:. 2757:. 2724:. 2710:: 2683:. 2661:: 2655:5 2631:. 2595:. 2565:. 2533:: 2504:. 2474:. 2452:: 2425:. 2401:: 2383:" 2370:. 2356:: 2329:. 2307:: 2277:. 2253:: 2245:: 2211:. 2189:: 2162:. 2140:: 2113:. 2089:: 2083:8 2062:. 2040:: 2013:. 1989:: 1983:8 1967:" 1954:. 1942:: 1916:. 1894:: 1867:. 1843:: 1835:: 1829:8 1808:. 1788:: 1782:5 1762:. 1750:: 1727:. 1715:: 1692:. 1668:: 1641:. 1619:: 1592:. 1570:: 1564:4 1539:. 1517:: 1490:. 1460:. 1420:. 1398:: 1371:. 1359:: 1336:. 1310:. 1288:: 1261:. 1226:. 1204:" 1187:. 1183:: 1150:. 1022:1 807:h 805:T 556:( 510:( 499:( 294:/ 291:f 288:ɪ 285:d 277:s 274:/ 270:( 243:( 36:. 20:)

Index

Clostridioides difficile (bacteria)
Clostridioides difficile infection

agar plate

Scientific classification
Edit this classification
Bacteria
Bacillota
Clostridia
Eubacteriales
Peptostreptococcaceae
Clostridioides
Binomial name
Synonyms
Prévot
syn.
bacterium
colon cancer
/sdɪf/
Gram-positive
species
spore
anaerobic
motile
pleomorphic
Gram staining
blood agar
oxygen
catalase

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.